LEO Pharma Investigational Site

Detroit, Michigan 48202

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Atopic Dermatitis Clinical Trial
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials